Retinal Degeneration Product Applications

1 applications found

Sustained-Release Drug Delivery Platforms for Retinal Diseases

Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...

ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you